For US Residents only

Background Glass

Once you and your doctor have decided that CAPLYTA is right for you

Find savings and support on your CAPLYTA prescription

CAPLYTA with me

Start and Stay with Confidence

ELIGIBLE* patients

may pay as little as

$
0
†
for 30-day or 90-day
prescriptions
and
as little as
$
0
for a generic
antidepressant
Image of savings card

get more savings with
90-day prescriptions

  • Save time – Fewer trips to the pharmacy
  • Save money – Lower out-of-pocket costs
Image of CAPLYTA savings card on a mobile device

text "CAPLYTA"
TO 26789

Text "CAPLYTA" to 26789 to download a digital CAPLYTA Savings Card to your phone and receive useful text messages about your prescription.

Text to download the CAPLYTA Savings Card to your phone and you'll also get:

  • Alerts on prescription savings
  • Updates on insurance coverage
  • Refill reminders and the option to order refills via text

Message and data rates may apply. Message frequency varies.
Text HELP for help. Text STOP to end. See Terms and Conditions and Privacy Policy.

Image of CAPLYTA Savings Card

Download the
SAVINGS CARD

Download and print your Savings Card. Then, simply bring it to your pharmacy, show it to the pharmacist, and see if you are eligible* to start saving on your CAPLYTA prescriptions.

Read the instructions and download your card below.

I have read and agree to the full Eligibility Criteria and Terms & Conditions*

I have a valid prescription for CAPLYTA

I am commercially insured

I am not receiving benefits under Medicaid, a Medicare drug benefit plan, TRICARE, or any other federal or state health program

I am 18 years of age or older

I am a resident of the U.S., excluding Puerto Rico

I agree to report the receipt of all Program benefits as may be required by my insurance provider

I will not seek reimbursement for all or any of the benefit received through this Program

Download Savings Card
*This offer is valid for eligible new or existing patients who are filling a prescription for CAPLYTA. Eligible patients must be 18 years of age or older, residents of the U.S., excluding Puerto Rico and have a valid prescription for CAPLYTA for a Food & Drug Administration approved indication. This Savings program is valid ONLY for patients with private commercial insurance and NOT valid for prescriptions reimbursed under Medicaid, a Medicare drug benefit plan, TRICARE, or other federal or state health programs. Offer is only good at participating retail pharmacies. Offer is not transferable, is not insurance, has no cash value, and may not be used in combination with other offers. Void if prohibited by law, taxed or restricted. All participants are responsible for reporting the receipt of all Program benefits as required by their insurance provider. No party may seek reimbursement for all or any of the benefit received through this Program. Johnson & Johnson reserves the right to rescind, revoke or amend the Program without notice at any time. Additional eligibility criteria apply. Please see below for Eligibility Criteria and Terms & Conditions.
†Maximum savings limit applies; patient out-of-pocket expense may vary.

Background Glass

CAPLYTA is covered by many types of insurance

93%
of americans have insurance coverage for caplyta

For those with Commercial Insurance only:

  • CAPLYTA is covered for ~90% of people with Commercial Insurance
  • Eligible* patients may pay as little as $0 for 30-day or 90-day prescriptions and as little as $0 for a generic antidepressant

For those with Medicaid and Medicare Part D:

  • CAPLYTA is covered for more than 99% of people
*This offer is valid for eligible new or existing patients who are filling a prescription for CAPLYTA. Eligible patients must be 18 years of age or older, residents of the U.S., excluding Puerto Rico and have a valid prescription for CAPLYTA for a Food & Drug Administration approved indication. This Savings program is valid ONLY for patients with private commercial insurance and NOT valid for prescriptions reimbursed under Medicaid, a Medicare drug benefit plan, TRICARE, or other federal or state health programs. Offer is only good at participating retail pharmacies. Offer is not transferable, is not insurance, has no cash value, and may not be used in combination with other offers. Void if prohibited by law, taxed, or restricted. All participants are responsible for reporting the receipt of all Program benefits as required by their insurance provider. No party may seek reimbursement for all or any of the benefit received through this Program. Johnson & Johnson reserves the right to rescind, revoke or amend the Program without notice at any time. Additional eligibility criteria apply. Please see above for Eligibility Criteria and Terms & Conditions.

IMPORTANT SAFETY INFORMATION

Medicines like CAPLYTA can raise the risk of death in elderly people who have lost touch with reality (psychosis) due to confusion and memory loss (dementia). CAPLYTA is not approved for treating people with dementia-related psychosis.

CAPLYTA and antidepressant medicines increase the risk of suicidal thoughts and actions in people 24 years of age and younger, especially within the first few months of treatment or when the dose is changed. Depression and other serious mental illnesses are the most important causes of suicidal thoughts and actions. Patients and their families or caregivers should watch for new or worsening depression symptoms, especially sudden changes in mood, behaviors, thoughts, or feelings. This is very important when CAPLYTA or an antidepressant medicine is started or when the dose is changed. Report any changes in these symptoms to your healthcare provider immediately.

Do not take CAPLYTA if you are allergic to any of its ingredients. Get emergency medical help if you are having an allergic reaction (e.g., rash, itching, hives, swelling of the tongue, lip, face, or throat).

CAPLYTA may cause serious side effects, including:

  • Stroke (cerebrovascular problems) in elderly people with dementia-related psychosis that can lead to death.
  • Neuroleptic malignant syndrome (NMS): high fever, confusion, changes in your breathing, heart rate, and blood pressure, stiff muscles, and increased sweating; these may be symptoms of a rare but potentially fatal condition. Contact your healthcare provider or go to the emergency room if you experience signs and symptoms of NMS.
  • Uncontrolled body movements (tardive dyskinesia, TD) in your face, tongue, or other body parts. TD may not go away, even if you stop taking CAPLYTA. It may also occur after you stop taking CAPLYTA.
  • Problems with your metabolism including high blood sugar, diabetes, increased fat (cholesterol and triglyceride) levels in your blood and weight gain. Your healthcare provider should check your blood sugar, fat levels, and weight before you start and during your treatment with CAPLYTA. Extremely high blood sugar levels can lead to coma or death. Call your healthcare provider if you have any of the following symptoms of high blood sugar: feeling very thirsty, hungry, sick to your stomach, needing to urinate more than usual, weak/tired, or confused, or your breath smells fruity.
  • Low white blood cell count. Your healthcare provider may do blood tests during the first few months of treatment with CAPLYTA.
  • Decreased blood pressure (orthostatic hypotension). You may feel lightheaded, dizzy, or faint when you rise too quickly from a sitting or lying position.
  • Falls. CAPLYTA may make you sleepy or dizzy, may cause a decrease in your blood pressure when changing position (orthostatic hypotension), and can slow your thinking and motor skills which may lead to falls that can cause broken bones or other injuries.
  • Seizures (convulsions).
  • Sleepiness, drowsiness, feeling tired, difficulty thinking and doing normal activities. Until you know how CAPLYTA affects you, do not drive, operate heavy machinery, or do other dangerous activities.
  • Problems controlling your body temperature so that you feel too warm. Avoid getting overheated or dehydrated while taking CAPLYTA.
  • Difficulty swallowing that can cause food or liquid to get into the lungs.

The most common side effects of CAPLYTA include sleepiness, dizziness, nausea, dry mouth, feeling tired, and diarrhea.

These are not all the possible side effects of CAPLYTA. Tell your healthcare provider if you have or have had heart problems or a stroke, high or low blood pressure, diabetes, or high blood sugar, problems with cholesterol, have or have had a low white blood cell count, seizures (convulsions), or kidney or liver problems.

CAPLYTA may cause fertility problems in females and males. You should notify your healthcare provider if you become pregnant or intend to become pregnant while taking CAPLYTA. There is a pregnancy registry for females who are exposed to CAPLYTA during pregnancy. CAPLYTA may cause abnormal involuntary movements and/or withdrawal symptoms in newborn babies exposed to CAPLYTA during the third trimester. Talk to your healthcare provider if you breastfeed or are planning to breastfeed as CAPLYTA passes into breast milk.

Tell your healthcare provider about all the medicines you're taking. CAPLYTA may affect the way other medicines work, and other medicines may affect how CAPLYTA works, causing possible serious side effects. Do not start or stop any medicines while taking CAPLYTA without talking to your healthcare provider. You are encouraged to report negative side effects of prescription drugs. Contact Intra-Cellular Therapies, Inc. at 1-888-611-4824 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

CAPLYTA is available in 42 mg, 21 mg, and 10.5 mg capsules.

INDICATIONS

CAPLYTA is a prescription medicine used in adults along with an antidepressant to treat major depressive disorder (MDD); to treat depressive episodes associated with bipolar I or bipolar II disorder (bipolar depression) alone or with lithium or valproate; or to treat schizophrenia. It is not known if CAPLYTA is safe and effective in children.

Please see Medication Guide, including Boxed WARNINGS.